Report

This report describes community-based tuberculosis care in Latin America, and field visits to selected community-based TB care projects to understand the origin, performance, acceptability, effectiveness, and sustainability of some existing DOTS projects. Three sites in Colombia and two in Bolivia, where the DOTS strategy is already implemented, were visited. The report demonstrates that lessons from a Latin American perspective on community-based TB care can help to understand and identify the role that the community plays in TB control in the region.

This report describes community-based tuberculosis care in Latin America, and field visits to selected community-based TB care projects to understand the origin, performance, acceptability, effectiveness, and sustainability of some existing DOTS projects. Three sites in Colombia and two in Bolivia, where the DOTS strategy is already implemented, were visited. The report demonstrates that lessons from a Latin American perspective on community-based TB care can help to understand and identify the role that the community plays in TB control in the region.

This report summarizes data from the national TB surveillance system for 2004 and describes trends since 1993. Findings indicate that although the 2004 TB rate was the lowest recorded in the United States since national reporting began in 1953, the declines in rates for 2003 (2.3%) and 2004 (3.3%) were the smallest since 1993. TB rates greater than the US average continue to be reported in certain racial/ethnic populations.

In 2002, congenital tuberculosis (TB), a rare disease with nonspecific signs and symptoms, was diagnosed in an infant in Florida. This report summarizes the investigation of the case in Florida.

This is an achievement report about the Global Drug Facility (GDF), a key initiative of the STOP TB Partnership, which has had a positive impact on the treatment of millions of TB patients globally since its establishment in 2001. By providing high-quality TB drugs to over 4.4 million people in some of the world's poorest countries, it has helped to save lives and has significantly strengthened global TB control efforts.

This report is from a consultation of experts held jointly by the World Health Organization (WHO) and Rockefeller Foundation. The report makes recommendations to the Stop TB Partnership (the Partnership) for confronting the health care workforce crisis in tuberculosis (TB) control. This is identified through three key areas for action: (1) building the evidence base for planning and advocacy, (2) positioning and advocacy, and (3) capacity building.

This report summarizes the recommendations of the Association of Public Health Laboratories Task Force on Tuberculosis Laboratory Services. The report describes in greater detail the actions and performance measures that were used to guide development and implementation of an integrated system for providing TB laboratory services. This report also provides information on the scientific basis of the recommendations.

This report provides a critical review of what is known about adherence to long-term therapies.This is achieved by looking beyond individual diseases. A broad range of policy options emerges by including communicable diseases such as tuberculosis and human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), mental and neurological conditions such as depression and epilepsy, substance dependence (exemplified by smoking cessation), hypertension, asthma and palliative care for cancer.

This report was conducted to systematically investigate the conditions under which Ultraviolet Germicidal Irradiation (UVGI) can be expected to mitigate the spread of Tuberculosis.

This report describes the distribution of TB cases among the population of California and the demographic and clinical characteristics of TB cases in 2003. It presents the risk factors for TB, drug resistance, treatment outcomes of the reporting jurisdictions in California, and recent trends.